the Q system is a repressible binary expression system for transgenic manipulations in living organisms. through protein engineering and in vivo functional tests, we report here variants of the Q-system transcriptional activator, including Qf2, for driving strong and ubiquitous expression in all Drosophila tissues. our Qf2, Gal4Qf and LexaQf chimeric transcriptional activators substantially enrich the toolkit available for transgenic regulation in Drosophila melanogaster.
be subdivided into three domains (Fig. 1a) that perform specific and independent functions: the DNA-binding and dimerization domain (DBD) containing a Zn 2 -Cys 6 motif that recognizes and binds to UAS or QUAS sites; a middle domain (MD) that has no clear function but that might be involved in endogenous regulation or stability; and a transcriptional activation domain (AD) that recruits molecular machinery necessary for transcription and that also binds the Gal80 or QS suppressor.
To overcome limitations of the original QF, any new QF variant should be capable of generating healthy transgenic flies when broadly expressed. In addition, it should exhibit strong transcriptional activity yet remain QS suppressible. We generated a series of constructs in which certain QF domains were modified ( Fig. 1a and Supplementary Fig. 1a ). In Gal4QF, QF2 w(eaker) and QF e , the QF AD was mutated to reduce activity by altering the charge on the C terminus. In QF2, QF2 w and LexAQF, the QF MD was completely removed; in QF f-i , the QF MD was partially removed. Finally, in Gal4QF, LexAQF, QF a-d and QF j-l , the QF DBD or QF AD were swapped for analogous Gal4 or LexA domains. To quantitatively measure activity levels, we performed luciferase assays in cultured Drosophila Schneider 2 (S2) cells (Fig. 1b) . To assay for QF toxicity, we attempted to generate transgenic animals expressing each construct under the pan-neuronal neuronal Synaptobrevin (nSyb; hereafter, nsyb) promoter ( Fig. 1, Supplementary Fig. 1 and Supplementary  Table 1 ). To allow direct comparison between transgenic constructs that use the same enhancer activation sequence (UAS, QUAS or LexAop), we used the PhiC31 integrase system and targeted all transgenic insertions to the same attP2 genomic landing site (3L: 68A4). However, direct comparison between transgenic factors using different activation sequences, e.g., UAS reporters ( Fig. 1c) versus QUAS reporters ( Fig. 1d) , cannot be made owing to differing activities of the reporters.
In relative luciferase activity assays and in vivo expression analyses, the optimal QF variants exhibited high activity levels ( Fig. 1b-f and Supplementary Table 1 ), were efficiently repressed by QS ( Supplementary Table 1 ) and produced healthy transgenic animals. We initially hypothesized that a potent QF AD may be the source of toxicity as it may be squelching cellular transcription factor components 16 , but QF variants that contained the original (QF2 and LexAQF) and mutated AD of QF (QF2 w and Gal4QF) were not toxic. Instead, constructs containing the MD of QF either failed to produce transgenic animals (QF d and QF g , Supplementary Fig. 1 ) or were extremely unhealthy (QF f ), thereby implicating the QF MD as the major source of QF toxicity. Deletion of this domain yielded two smaller QF variants, QF2 and QF2 w , which exhibited strong but differing QF activities improved and expanded Q-system reagents for genetic manipulations in vitro (2,089 ± 477 s.e.m. and 685 ± 44 s.e.m. times above control, respectively; P = 0.00064; Kolmogorov-Smirnov test) and in vivo (Fig. 1c-e and Supplementary Fig. 1c ). Both QF2 and QF2 w were capable of generating healthy pan-neuronally expressing transgenic animals. Thus, the QF MD is dispensable for full QF activity, yet it is the major source of QF toxicity in vivo.
We assessed expression patterns and strength of the transactivators at 18 °C, 25 °C and 29 °C with both membrane-tagged GFP (Supplementary Fig. 2 ) and nuclear LacZ reporters (Fig. 1f) . In findings similar to the in vitro results (Fig. 1b) , QF2, QF2 w , Gal4QF and LexAQF had activity levels comparable to that of Gal4 and could be robustly repressed by QS at all tested temperatures. In agreement with Mondal et al. 17 , we found that Gal4 activity did not vary with temperature. This contrasts with the temperature dependence often observed with many GAL4 enhancer traps 18 , which likely reflects the use of temperaturesensitive elements in these constructs 1 .
We quantified the expression level for LexA BD :QF AD chimeric proteins (LexAQF and QF l ) with only a GFP reporter ( Fig. 1e and Supplementary Figs. 1d and 2) , as LexAop-nuc-lacZ reporter lines were not available. Both constructs drive strong expression in vivo, and pan-neuronally expressing transgenic animals were healthy. Fig. 2 ) and could be repressed by QS at all temperatures (data not shown). The LexAQF chimeras offer a useful alternative to LexA:VP16 and LexAGal4 transcriptional activators 2 in that LexAQF chimeras are independent of the Gal4-UAS system and can be reversibly suppressed by QS ( Fig. 1e and Supplementary Fig. 1d ).
The nuc-lacZ quantification of QS-suppressed activity of QF2 in vivo ( Fig. 1f) suggested that a number of cells were still weakly labeled and detectable by our algorithm. To further validate the ability of QS to functionally inhibit QF2 and QF2 w , we performed whole-animal rescue experiments. We drove the expression of the temperature-sensitive endocytotic recycling protein encoded by shibire (at 29 °C) with nsyb-QF2 or nsyb-QF2 w , which did not result in surviving adults, as expected. This lethality was fully rescued in flies that also carried a tubulin-QS transgene (Supplementary Table 2 ), indicating that QF2 and QF2 w are efficiently suppressed by QS in vivo. In addition, the activity of all QF AD variants (QF2, QF2 w , Gal4QF and LexAQF) could be regulated by feeding quinic acid to larvae or adult flies ( Supplementary Fig. 3 ). Quinic acid had a stronger effect on peripheral receptor neurons than on central brain neurons, presumably reflecting differential exposure of the neurons to quinic acid.
The new transactivators (QF2, QF2 w , Gal4QF and LexAQF), together with Gal4, offer the possibility of using Gal4, LexA and Q systems simultaneously in overlapping subsets of cells. We verified that activity of any two of these transactivators in the same cells did not result in toxicity or reporter silencing effects by generating all possible binary combinations of the nsyb transactivator flies (Supplementary Fig. 4) .
To test whether expression of the new transactivators might cause toxicity in non-neuronal tissues, we generated flies that express QF2, QF2 w , Gal4QF and LexAQF under the control of the ubiquitous promoters tubulin (alphaTub84B) and actin (act5C). These flies were viable, and activity of the transactivators was robust in late embryos (data not shown), larvae and adult flies ( Fig. 2a) . These ubiquitous drivers could be effectively suppressed by QS in the whole larvae or adult flies ( Fig. 2a and Supplementary Fig. 5 ). Examination of imaginal discs (epithelial tissue) and larval body walls (muscle) ( Supplementary Fig. 5a,b ) confirmed the broad transactivator expression patterns of QF2, QF2 w , Gal4QF and LexAQF.
Evidence that Gal4, when driven at very high levels, could be toxic to the fly was first found in experiments using the strong synthetic eye promoter pGMR 19, 20 . pGMR-QF2 w transgenic animals exhibited strong QF-induced GFP expression in the eyeantennal imaginal disc ( Fig. 2b ), yet they had no morphological eye defects at the adult stage. These results suggest that QF2 w , even when very strongly expressed, was not toxic to the cell.
As a final readout of QF2 and QF2 w effects in vivo, we examined three different behaviors in flies pan-neuronally expressing QF2, QF2 w or GAL4 in the same w 1118 genetic background ( Fig. 3 and Supplementary Table 3 ). Behaviors are a sensitive measure of in vivo health: they require key processes, such as development, neuronal wiring and neuronal function, to be unaffected. The nsyb-QF2 and nsyb-QF2 w flies were indistinguishable from nsyb-GAL4 controls in olfactory attraction to apple cider vinegar and humidified air, but they were slightly but significantly (P = 0.0275 and P = 0.0302, respectively) less repelled by CO 2 gas than the controls (Fig. 3a) . nsyb-QF2 and nsyb-QF2 w flies exhibited phototactic responses comparable to those of nsyb-GAL4 flies and wild-type controls (Fig. 3b) . In locomotor activity assays ( Fig. 3c-f 
UAS-mtdT-3xHA
13xLexAop-mCD8-GFP figure 2 | In vivo expression driven by tubulin, actin and GMR promoters. (a) Ubiquitous expression of GFP or membrane-targeted tandem dimer Tomato (mtdT) reporters in third instar larvae (left; representative of n = 4-6) and in adult flies (right column; representative of n = 5). Larvae carry a tubulin or actin driver line and an mtdTomato or mCD8-GFP reporter as well as a tubP-QS transgene where indicated. Adult flies (center) are imaged next to the controls (left) that bear only the TA or only effector transgenes (dashed white outline). The rightmost subpanels (marked by "+tubP-QS") show flies that, in addition to the indicated driver and reporter transgenes, also carry tubP-QS. Expression of act-LexAQF driver is visualized with an mCD8-GFP reporter. Imaging settings were identical for all images, apart from the duration of exposure, which is indicated for each image. Table 3 ). Taken together, these results demonstrate that pan-neuronal expression of QF2 and QF2 w is compatible with proper neuronal development and function.
In summary, we have developed two next-generation versions of QF-QF2 and QF2 w -that have dramatically reduced toxicity and can be expressed broadly in vivo. QF2 is best suited when strong transcriptional activity is required in subsets of cells. QF2 w is optimal for broad expression patterns or strong promoters. We have also developed chimeric Gal4QF and LexAQF transactivators which, while still activating UAS-geneX and LexAop-geneX effectors respectively, are QS suppressible, quinic acid regulatable and Gal80-insensitive. These transactivators substantially expand the range of possible applications of the Q system by itself as well as in combination with Gal4-UAS and LexA-LexAop for intersectional targeting.
methods
Methods and any associated references are available in the online version of the paper. Daily activity (# of beam crossing) 29 28 20 21 n.s. n.s. The QF AD was predicted as in Wei et al. 7 . An InterProScan 23 of QF predicted a conserved fungal transcription factor domain at amino acids 372-465, which was the basis for construct QF i .
Toxicity of transgenic QF constructs. Several constructs were generated as detailed below that failed to produce transgenic animals despite multiple attempts (>1,000 embryo injections per construct). Pan-neuronal Synaptobrevin promoter (nsyb) constructs that failed to produce transgenic animals included nsyb-QF in a piggyBac transformation vector for random genomic insertions (pXL-BACII-nsyb-QF-hsp70) and nsyb-QF in an attB vector directed to attP2 (pattB-nsyb-QF-hsp70).
The following pan-tissue constructs that used the tubulin promoter (tubP) failed to produce transgenic animals: tubulin P-QFcodon_deoptimzed (cdo), in a piggyBac transformation vector (pXL-BAC-tubulinP-QFcdo); tubulinP-QF::QF2AD weak , in a piggyBac transformation vector that contains the same AD mutant as in QF2 w but with full-length QF (pXL-BAC-tubulinP-QF2M1); and tubulinP-QF::QF e AD, in a piggyBac transformation vector that contains the same AD mutant as in QF e but with full-length QF (pXL-BAC-tubulinP-QF2M2).
Note that nsyb-QFcdo, in a piggyBac transformation vector for random genomic insertions, was able to generate transgenic animals. Of the ten original lines, induced QUAS-mCD8GFP activity was weak, and none of the lines exhibited pan-neuronal |expression. In addition, as we were unable to generate tubulinP-QFcdo transgenic animals, QFcdo constructs were not characterized further.
Our initial hypothesis was that the QF AD was the major source of QF toxicity. To circumvent this toxicity when generating QF transgenic animals, we injected constructs into flies containing a tubP-QS transgenic background. However, this did not help yield transgenic animals. Our recent findings suggest this is likely due to the MD of QF being the major source of toxicity, which would not be attenuated by QS expression. Nonetheless, transgenic animals containing the Gal4 binding domain and QF AD (QF b , Supplementary Fig. 1 ) demonstrated the strongest activity of all the constructs and were not as healthy as the same QF chimera (Gal4QF, Fig. 1 ) containing the QF2 w AD. This suggests that a fully potent QF AD might, in some instances, contribute toward in vivo toxicity. We note that even Gal4 can be toxic when expressed at high levels 16, 19 .
Recombinant DNA construction. Plasmids were constructed by standard procedures including enzyme digestions, PCR and subcloning. Some of the plasmids were manufactured using the In-Fusion HD Cloning System (Clontech, Cat #639645). Plasmid inserts were verified by DNA sequencing. Apart from the constructs used in the reported experiments, we describe four additional constructs (pPT-QF2-hsp70, pattB-DSCP-QF2-hsp70, pattB-hsp70-QF2-hsp70, pCasper-QF2-hsp70) that may be useful for creating new QF2 lines. Primer sequences are shown in Supplementary Table 4. QF codon variants. QFrco, QF recodonized. The original QF sequence from Neurospora often yielded tracheal expression in enhancer-trap constructs 3 . This was likely due to a cryptic tracheal enhancer in the QF gene sequence. To eliminate this tracheal enhancer, the entire coding region of QF was recodonized (DNA2.0, Inc.) by manually choosing codons expected to yield average expression (http://www.kazusa.or.jp/codon/cgibin/showcodon.cgi?species=7227). Transgenic flies expressing QFrco enhancer traps no longer exhibited background tracheal expression (data not shown).
QFcdo, QF codon-deoptimized. A Drosophila codon deoptimized variant of QF led to reduced expression levels in transgenic constructs (data not shown). QFcdo enhancer trap flies induced weak reporter activity and also no longer exhibited tracheal expression.
Chimeric and deletion cloning strategy. Chimeric constructs and deletions were generated by a multistep PCR process using a high-fidelity Taq polymerase (Phusion Taq, NEB). PCR fragments were generated that had terminal regions of sequence overlap (typically 17-25 base pairs to achieve a predicted T m of 62-65 °C) to other PCR fragments. The overlapping PCR fragments were used in a second round of PCR in which the overlapping PCR fragments each acted as primers for PCR amplification. After five cycles, additional oligos were included to selectively amplify full-length PCR products. All constructs were sequence verified before generating transgenic animals. All pattB-nsyb-geneX-hsp70 constructs were generated by inserting an EcoRI/AatII digested PCR product (Gal4, QF a -QF e , GAL4QF) or In-Fusion compatible PCR product (QF2, QF2 w , QF f -QF k , LexAQF, LexAG4QF) into the EcoRI/AatII site of QF-excised pattB-nsyb-QF-hsp70. Chimera construction details are listed in Supplementary Table 5. S2 cell culture constructs. pAC-QF x (Addgene #46089-46105). These plasmids contain QF x variants under the control of the actin5c promoter for expression in S2 cell culture. The vector backbone for these constructs was obtained by digesting the pAC-QF plasmid 3 with BamHI and NotI to remove the QF gene. New QF variants were PCR amplified from corresponding pattB-QF x plasmids and ligated into the vector backbone by an In-Fusion reaction. For PCR amplification, the same forward primer was used for all QF variants in combination with Gal4 DNA-binding domain (IF_FOR_GAL4DBD), QF DNA-binding domain (IF_FOR_QFDBD) and LexA binding domain (IF_FOR_ LEXADBD) primers. Likewise, the same reverse primer was used to PCR-amplify constructs with a Gal4 AD (IF_REV_GAL4AD) or an original QF AD (IF_REV_QFAD). Constructs with the LexA binding domain were amplified with reverse primer IF_REV_ LEXADBD. The reverse primers for the following were GAL4QF, IF_REV_GAL4QF; QF2 w , IF_REV_QF2W; QF f , IF_REV_QF_F. Additional constructs used for generating transgenic animals. pCasper4-tubP-QF2-hsp70 (Addgene #46127). This construct was used to generate fly lines with random genomic insertions of the tubulinP-QF2 transgene. The vector backbone was obtained by cutting pCasper4-tubP-GAL80 (ref. 25) with NotI and XhoI. The QF2-hsp70_terminator insert was PCR amplified from the pattB-QF2 plasmid with forward primer IF_FOR_TUB_QF2 and reverse primer IF_REV_TUB_QF2, and cloned into the digested vector by an In-Fusion reaction.
pCasper-act(B)-QF2 w -hsp70. This plasmid was used to generate fly lines with random genomic insertions of the actin-QF2 w transgene. Transgenic flies are not described in this paper owing to the availability of a stronger ubiquitous driver line, obtained with pCasper-tubP-QF2w-hsp70, but are available upon request. pCasper-act(B) (DGRC stock#1068) was digested with EcoRI and PstI, QF2-hsp70 was PCR amplified from pattB-nsyb-QF2 with forward primer IF_FOR_ACT_QF2W and reverse primer IF_REV_ACT_QF2W and cloned into the digested vector by an In-Fusion reaction.
pCasper-tubP-QF2 w -hsp70 (Addgene #46128). The 371-bp terminus of QF2 w was excised from pattB-nsyb-QF2w-hsp70 by digestion with NheI/XhoI and cloned into pCasper4-tubulinP-QF2-hsp70 in which the QF2 C terminus had been excised by NheI/XhoI digestion.
pCasper-act-GAL4QF. This construct was used to generate transgenic flies with random genomic insertions of the actin-GAL4QF transgene. pCasper-act(B)-QF2 w -hsp70 was digested with BamHI and NotI to remove QF2w-hsp70_terminator fragment. The GAL4QF-hsp70_terminator fragment was PCR amplified from 5-pattB-synaptobrevin-G4BDDM-QFADM1-hsp70 with the forward primer IF_FOR_ACT_GAL4QF and reverse primer IF_REV_ACT_GAL4QF and subcloned into the cut pCasper-act vector by an In-Fusion reaction.
pCasper-act-LexAQF. This construct was used to generate transgenic flies with random genomic insertions of the actin-GAL4QF transgene. pCasper-act(B)-QF2 w -hsp70 was digested with BamHI and NotI to remove QF2w-hsp70_terminator fragment. The LexAQF-hsp70_terminator fragment was PCR amplified from pattB-synaptobrevin-14-LexA-QF-hsp70 with the forward primer IF_FOR_ACT_LEXAQF and reverse primer IF_REV_ACT_LEXAQF and subcloned into the cut pCasper-act vector by an In-Fusion reaction.
pGMR-QF2 w (Addgene #46130). This plasmid was used to generate random genomic insertions of QF2 w , driven by the strong GMR eye-specific promoter 19, 20 . Vector pGMR-GAL4 was digested with EcoRI to remove the GAL4 gene, and QF2 w was PCR amplified from pAC-QF2 w with forward primer IF_FOR_GMR_QF2W and reverse primer IF_REV_GMR_QF2W, and subcloned into the digested pGMR vector by an In-Fusion reaction.
Additional plasmids generated for QF2. pCasper-act(B)-QF2 w -act_term (Addgene #46126). QF2 w was excised from pAC-QF2w
by digestion with BamHI/NotI and ligated into pCasper4-actin5cB-QF2 digested with BamHI/NotI to excise QF2.
pPT-QF2-hsp70 (Addgene #46136). Vector pPTGAL 26 was digested with PstI, and QF2-hsp70 PCR amplified from pattB-hsp70-QF2-hsp70 with forward primer IF_FOR_PPT_QF2 and reverse primer IF_REV_PPT_QF2 and subcloned into the digested vector by an In-Fusion reaction. This construct contains a minimal hsp70 promoter and allows for convenient subcloning of enhancers upstream of QF2.
pattB-DSCP-QF2-hsp70 (Addgene #46133). The pattb-QF-hsp70 plasmid 3 and pattb-syb-QF2 were both cut with EcoRI and ZraI, and the isolated QF2 insert was ligated into the digested pattb-hsp70 vector using the Rapid DNA Ligation Kit (Roche). The pattb-QF2-hsp70 plasmid was digested with EcoRI and BamHI, and the DSCP promoter PCR amplified from pattB-DSCP-QF-SV40 (ref.
3) with forward primer IF_FOR_DSCP_QF2 and reverse primer IF_REV_DSCP_QF2, and cloned into the digest vector by an In-Fusion reaction. This PhiC31 integrase compatible plasmid utilizes the DSCP promoter 27 to allow for the cloning of enhancer regions to drive QF2 expression.
pattB-hsp70P-QF2-hsp70T (Addgene #46134). The pattb-QF2-hsp70 plasmid was digested with EcoRI and BamHI, and the hsp70 promoter PCR amplified from pUAST 1 with forward primer IF_ FOR_ATTB_QF2 and reverse primer IF_REV_ATTB_QF2, and subcloned into the digested vector by an In-Fusion reaction. This PhiC31 integrase compatible plasmid utilizes the hsp70 minimal promoter to allow for the cloning of enhancer regions to drive QF2 expression.
pCasper-act(B)-QF2-act_term (Addgene #46125). QF2 was PCR amplified from pattB-nsyb-QF2 using oligos IF-FOR-pCasper-ActB-QF7 and IF-REV-pCaspActB-QF7 and In-Fusion (Clontech) cloned into pCasper-act(B) digested with BamHI.
pCasper4-QF2-hsp70 (Addgene #46135). The QF2-hsp70 cassette was PCR amplified from pattB-nsyb-QF2-hsp70 to include flanking XbaI restriction sites and inserted into the XbaI site of pCasper4 (DGRC stock# 1213).
Progenitor plasmids for constructs described in this paper. pattB-synaptobrevin-QFcdo-hsp70. The Synaptobrevin promoter was PCR amplified from pattB-nsyb-DSCP-QF-SV40 to include flanking BamHI and EcoRI restriction sites. The tubulin promoter from pattB-tubulinP-QFcdo-hsp70 was excised by digestion with BamHI/EcoRI and replaced with the digested n-Synaptobrevin PCR product.
pattB-nsyb-DSCP-QF-SV40. The n-Synaptobrevin promoter was PCR amplified from the plasmid pPTGAL4+n-syb (a vector containing the n-Synaptobrevin promoter upstream of the CMV minimal promoter, kindly provided by J. Simpson, Janelia Farm Research Campus) to include flanking EcoRI restriction sites. The EcoRI digested PCR product was ligated into the EcoRI restriction site of pattB-DSCP-QF 3 .
pattB-tubulinP-QFcdo-hsp70. The hsp70 terminator from pXN-QF-hsp70 was PCR amplified to include AscI/NotI restriction sites (hsp70-AscI-FOR, hsp70-NotI-REV) and ligated into the pattB-tubulinP-QFcdo-SV40 vector digested with AscI/NotI to excise the SV40 terminator. These flies were raised on standard fly medium until they were 2-to 3-d-old adults, at which point they were transferred into vials containing 10 ml of 1% agarose (Denville Scientific, Cat #CA3510-8) supplemented with 0.1 g of sucrose (Sigma, Cat #S0389) and 0.6 g of QA (Sigma, Cat #138622). The vials also contained yeast paste made from dry yeast and QA solution (3 g of QA per 10 ml of H 2 O, neutralized to pH 6.5 by 10 mM NaOH solution). The same QA solution was used to moisten a Kimwipe that was embedded into the agarose gel. Flies were kept in these QA-containing vials for 3 d, after which brains were dissected and immunostained as described below.
S2 cell transfections and luciferase assays. S2 cells (Life
Technologies, Cat #R690-07) were cultured in Express Five SFM (serum-free medium, Gibco, Cat #10486-025), supplemented with 18 mM l-glutamine (Gibco, Cat #25030-081) and penicillin/ streptomycin/l-glutamine mixture (25,000 units/25,000 µg/ 200 mM, Lonza, Cat #17-718R, 4.5 ml per 1 liter of SFM). The cells were maintained in 75-cm 2 tissue culture flasks (Sarstedt, Cat #83.1811.002) at room temperature and atmospheric CO 2 , and passaged every 4-6 d for no more than 26 generations. Cells were tested for mycoplasma infection by a PCR reaction using primers specific to 16S mycoplasma ribosomal RNA coding regions. For transfections, 0.3 ml per well of cell-containing medium and 0.3 ml per well of fresh medium were placed into 24-well plates (Corning, Cat #3524) 24 h before transfection. All transfections were performed using Effectene Transfection Reagent (Qiagen, Cat #301425). 200 ng of DNA (per well) were mixed with Effectene reagent, enhancer and buffer according to manufacturer's instructions, supplemented with 0.4 ml (per well) of fresh medium and carefully pipetted into the wells. For QF x activity assays, each well was transfected with 12.5 ng of a transcription factor pAC-QF x plasmid, 50 ng of firefly luciferase reporter plasmid (pLexAop-luc2, pQUAS-luc2, or pUAS-luc2), 50 ng of Renilla luciferase plasmid (pAC-hRluc) for normalization and 87.5 ng of pBluescript (pBS-KS) plasmid. In the controls, 12.5 ng of the transcription factor plasmid were replaced by 12.5 ng of pBluescript. We always transfected one of the wells in each 24-well plate with 200 ng of pBluescript and left one well untransfected for control purposes. For QS repression assays, 87.5 ng of pBluescript were replaced by 87.5 ng of pAC-QS plasmid and cotransfected with pAC-QF x , firefly and Renilla luciferase plasmids. Controls for QS assays were the same as for QF activity assays (firefly and Renilla reporters and pBluescript plasmid). Cells were lysed 48 h after transfection by replacing the medium in the wells with 0.1 ml of passive lysis buffer (PLB) from the Dual Luciferase Reporter Assay System (Promega, Cat #E1980) and shaking the plates at room temperature for 10 min. For luciferase activity measurements, the original lysates were diluted 10,000 times in PLB and analyzed by a Fluorostar Optima (BMG Labtech) plate reader immediately after lysing. Each lysate sample was placed into three different wells in a 96-well plate; from each well the luminescence was measured automatically six times (once per second) after the addition of firefly luciferase substrate and six times (once per second) after the addition of Renilla luciferase substrate. The relative luminescence (RL) of each well was calculated as Renilla where X is the average luminescence signal in response to luciferase X substrate. The average was calculated for measurements 3-6 because the first two measurements were often substantially different from the following four. To obtain the relative luciferase activity (RLA, Fig. 1b) , the RL was averaged between the three wells that contained the same lysate. Next, this average RL, calculated npg for wells with transcription factor, was divided by a control RL, obtained from a corresponding control wells (only reporter plasmids without transcription factor). _measurement Renilla
RLA
Thus, one RLA measurement was obtained for each of the wells from the original 24-well plate that contained a transcription factor plasmid. Figure 1b shows the results of four or five RLA measurements for each construct, apart from pAC-QF2 w , which was measured ten times. Each RLA measurement was obtained from independent transfections performed on different days.
Immunohistochemistry. Dissection of larval imaginal discs and adult brains, immunostaining and confocal imaging were done as described previously 28 . In short, brains of third instar larvae or 4-to 5-d-old adult flies were dissected in PBS, fixed for 20 min at room temperature, washed at room temperature in PBT for 5-6 h, blocked in 5% NGS in PBT and placed in primary antibody mixes for three nights at 4 °C. Next, the brains were washed for several hours in PBT at room temperature and placed in secondary antibodies mix for two nights at 4 °C. The following day the brains were washed in PBT and placed in mounting solution (Slow Fade Gold) overnight at 4 °C, and mounted on a microscope slide the next day. To visualize GFP expression, we used rabbit anti-GFP (Life Technologies #A11122, 1:100), chicken anti-GFP (Aves Labs Inc., #GFP1020, 1:250) and mouse nc82 (DSHB, 1:25; not used for larval brains) primary antibodies; for LacZ experiments we used preabsorbed rabbit anti-β-galactosidase (MP Biomedicals #08559762, 1:50), Rat-ELAV-7E8A10 anti-ELAV (DSHB, 1:50) and mouse nc82 (1:25) primary antibodies; to visualize mtdT-3HA, we used rat anti-HA (Roche #11867423001) primary antibody (1:100). Secondary antibodies used for GFP expression were Alexa 488 anti-rabbit (Invitrogen #A11034, 1:200) and For mtdT-3HA experiments: Cy3 anti-rat (Jackson ImmunoResearch #112-165-167, 1:200). Larval imaginal discs were stained in DAPI (1:100) for 10 min during one of the PBT washes after secondary antibody incubation.
Whole-animal imaging. Third instar larvae were placed on a small metal plate on top of crushed ice or on a temperaturecontrolled plate and imaged by a Zeiss SteREO DiscoveryV8 microscope equipped with a GFP-470 and ds-Red filters and a Jenoptik ProgRes MF cool CCD camera. Monochrome images were acquired in ProgRes Mac Capture Pro 2.7 software and stored in .tif format. Adult flies (3-5 d old) were anesthetized on a CO 2 pad and imaged as described for larvae. Images that are compared to each other were obtained under identical hardware and software settings.
Confocal imaging and image processing. Brains were imaged on an LSM 700 Zeiss confocal microscope equipped with a LCI Plan-Neofluar 25×/0.8 Imm Korr DIC M27 water-immersion objective, at 512 × 512 pixel resolution, with 1-µm or 2.37-µm z steps. See Supplementary Note for details. Zen 2012 Release Version 8 software was used for image acquisition. Microscope settings were kept the same for the genotypes that were later compared to each other, i.e., all nsyb-QF x /(Q)UAS-mcd8-GFP brains, all nsyb-QF x /(Q)UAS-nucLacZ brains, etc.
For illustration purposes, confocal images were processed in ImageJ to collapse z stacks into a single image using maximumintensity projection and to pseudocolor different acquisition channels using an RGB Merge plug-in. No other image processing was performed on the confocal data.
To quantify LacZ expression, we used a custom-written Matlab (MathWorks) script. The script (Fig. 1f) identified cells in the elav channel and used the outlines of these cells as a mask to select the corresponding pixels in the LacZ channel. Then it calculated the average intensity of these pixels in the LacZ channel and normalized it by the average intensity of initially selected elav cells. The algorithm for identifying cells was adapted from a script by T. Kuo and J. Buyn (Center for Bioimage Informatics, also used in ref.
3). The cells were identified for every image in a z stack, and the intensity measures of each image were averaged to produce one number per brain.
To quantify GFP expression ( Supplementary Fig. 2) , we identified pixels with above-threshold intensity in the GFP channel on each image of a z stack. Next, we calculated the average intensity of the identified pixels, producing one number per imaged brain. Finally, we averaged the intensity measures of separate brains.
Scanning electron microscopy imaging. Heads of 3-to 5-d-old female flies were mounted without any processing onto aluminum stubs with double-stick carbon tape (Ted Pella) or Blu-Tack (Bostik). Images were acquired at 200× magnification with a Leo 1530 field emission scanning electron microscope operating at 1 kV.
Behavioral tests. All flies used in behavioral tests were outcrossed to the same wild-type isoD1 whitebackground for five generations. Control and experimental data sets were compared using the nonparametric Kolmogorov-Smirnov test.
npg Phototactic behavior. Experiments were conducted in a photography dark room using overhead infrared lights for illumination. The F15T8/WW fluorescent lamp light source was switched off during control experiments. 50 male and 50 female 5-d-old flies were used for each experiment. Prior to the assay, flies were kept in vials with regular fly medium at room temperature. The experimental setup was as described previously 29 and consisted of 21 cell culture tubes (14 ml, BD Falcon, REF 352059), arranged in two rows of 10 and 11 tubes so that the open ends of the tubes were facing each other. For example, tube 0 was opposite tube 0′, tube 1 was opposite tube 1′ and so on. Flies were initially placed in tube 0 and given 2 min to walk toward the light source and into tube 0′. Next, tube 0′ was shifted into register with tube 1, the flies were tapped down from tube 0′ into tube 1 and again given 2 min to walk toward the light and into tube 1′ and so on. In total, each fly had ten chances to walk toward the light source in the course on an experiment. The phototaxis index (PI) was calculated as where N i is the number of flies in tube i at the end of the experiment. PI equals to the average number of times a fly walked toward the light source, with a PI = 10 indicating that all flies always walked toward the light and PI = 0 meaning that no flies walked toward the light. We repeated the experiment and the lights-off control 4-7 times for each genotype. Figure 3b represents the data as an average PI for each genotype and experimental condition; error bars show s.e.m.
Activity and sleep assays. For activity/sleep measurements, flies were outcrossed five times into iso31 background (Bloomington #5905). Flies were entrained to a 12:12 h LD cycle for at least 2 d before being assayed. Flies were kept in glass tubes containing 5% sucrose and 2% agar, and monitored using the Drosophila Activity Monitoring System (Trikinetics). Activity counts from 4-to 7-d-old female flies were collected in 1-min bins in the LD cycle at 25 °C for 2 d. Activity/sleep parameters were computed using Matlab-based custom software. Sleep was identified as periods of inactivity lasting at least 5 min. For circadian behavior measurement, activity counts were recorded in 30-min bins in constant darkness over a 6-d period and analyzed using ClockLab (Actimetrics). Period length (τ) was determined by χ 2 periodogram analysis, and rhythm strength was measured by relative FFT, calculated by fast Fourier transform analysis.
Olfactory behaviors in the four-field assay. These olfactory experiments were conducted as described previously 30 . The experimental setup consisted of a temperature-controlled lightproof chamber (45 cm × 27 cm × 49 cm) that was equipped with four air inlets, a CCD camera (Sony CCD IR XC-E150 with Pentax 12.5mm 1:1.4 TV lens) and two arrays of infrared LEDs. The chamber was designed to accommodate a rectangular arena (23 cm × 23 cm × 3 cm), the corners of which could be connected to the four air inlets. The arena consisted of a Teflon base sandwiched between two glass plates. The bottom glass plate had a hole (diameter = 6 mm) in the middle to let out the air that was pumped into the arena from the corners. The arena was placed horizontally inside the chamber and filmed by a CCD camera from above. The video data were acquired at 30 f.p.s., 640 × 480 pixels, by a custom-written GUI. Immediately after acquisition, the data were processed by custom-written Matlab scripts and stored as a .mat file. The data structure contained information about coordinates of each detected fly at each point in time, and also about trajectories of individual flies, whenever the trajectories could be resolved unequivocally. 25 female and 25 male flies were starved for 41-43 h before each experiment and were 5 d old when tested. The flies were transferred without anesthesia into the four-field arena that was immediately placed into the experimental setup and flushed with clean dry air (DA) at 0.1 l/min from each corner for 20 min. We recorded the flies' activity for 10 min in DA and for the following 10 min with 5% CO 2 , water vapor, or 5% apple cider vinegar in water blown into one quadrant of the arena. Three other quadrants were flushed with DA at all times. Experiments were conducted in the dark, at 25 °C maintained in the experimental chamber. Flies' activities were quantified as an attraction index (AI) calculated for the odorant quadrant. The 10-min DA recording served as a control for the odor experiment. If the flies' activity was too low or they were distributed unevenly in the arena (|AI|>0.15) during the 10-min DA recording, this group of flies was not tested with an odorant. The AI was calculated as
where N odorant is the number of data points in the odorant quadrant during 10 min, and N DA is the average number of data points in the other three quadrants that were always flushed with DA. Each walking fly generated 30 data points per second.
A fly was deemed stationary if its speed was consistently below 4.5 pixel/s for 3.3 s. The data points from stationary flies were discarded. AI = −1 corresponds to complete repulsion from the odor quadrant, and AI = 1 corresponds to complete attraction toward the odor quadrant.
Code availability. Custom-written Matlab scripts, used for quantifying confocal imaging data and for behavioral analyses, are available upon request.
Reproducibility. Our sample size (Fig. 3) is similar to that normally used in the literature for these kinds of experiments. No data were excluded from the analysis. No randomization was used, and no blinding was used.
